CARsgen appoints Dr. Raffaele Baffa as Chief Medical Officer

Dr. Baffa has a wealth of experience in the pharmaceutical industry and research institutes, holding various management positions in multinational corporations and biotechnology companies.

CARsgen Therapeutics Holdings of China, a company specializing in innovative CAR T cell therapies for the treatment of hematological malignancies and solid tumors, announces that Dr. Raffaele Baffa has been appointed as the company’s Chief Medical Officer (CMO), responsible for overseeing global clinical development strategies and operations for innovative product candidates in the company’s pipeline. Dr. Baffa will report to Dr. Zonghai Li, Founder, Chairman, CEO, CSO of CARsgen Therapeutics Holdings Limited.

Dr. Baffa has a wealth of experience in the pharmaceutical industry and research institutes, holding various management positions in multinational corporations and biotechnology companies.

Prior to joining CARsgen, Dr. Baffa served as Chief Medical Officer and Executive Vice President of Research and Development at Ziopharm Oncology, which was renamed Alaunos in January 2022. Prior to Ziopharm Oncology, Dr. Baffa was Head of Research and Development and Medical Director at Medisix Therapeutics, a company focused on the development of novel immune cell therapies.

Dr. Baffa was Vice President, Oncology Therapeutic Area Leader, Global Clinical Development of Shire Pharmaceuticals, and following the acquisition of the Oncology Division by Servier Pharmaceuticals, Dr. Baffa served as the Chief Medical Officer of Servier Pharmaceuticals. Dr. Baffa has also held senior positions in well-known pharmaceutical companies, such as Pfizer and Sanofi.

Dr. Baffa obtained an MD from the University of Padua, School of Medicine and a Ph.D. in Molecular Biology and Pathology from the University of Parma in Italy.

About Hector Hedgepeth

Check Also

Silence Therapeutics Announces First Quarter 2022 Results

LONDON–(BUSINESS WIRE)–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, …